Tr. Levin et al., A COST-ANALYSIS OF A HELICOBACTER-PYLORI ERADICATION STRATEGY IN A LARGE HEALTH MAINTENANCE ORGANIZATION, The American journal of gastroenterology, 93(5), 1998, pp. 743-747
Objectives: We sought to describe the effect of a Helicobacter pylori
eradication strategy on health care costs among a cohort of health mai
ntenance organization (HMO) members with peptic ulcer disease (PUD), M
ethods: Patients were identified from an outpatient diagnosis database
and verified at chart review to have new-onset PUD by upper endoscopy
or upper gastrointestinal radiographic series. Health plan registrati
on and accounting databases were used to track costs over 12 months af
ter initial diagnosis. Costs mere analyzed separately for an initial 2
-month interval and a 10-month follow-up period. Inpatient and pharmac
y costs are those directly attributable to PUD (either a PUD-related d
ischarge diagnosis or an antiulcer medication prescription). Outpatien
t costs are total costs, All cost differences were adjusted for age an
d gender. Results: Twenty-seven of 93 patients meeting selection crite
ria received H. pylori treatment. During the 2-month treatment window,
adjusted PUD-related inpatient costs mere higher for the H. pylori tr
eated group (difference, $234.00/person), whereas total outpatient cos
ts and PUD-related pharmacy costs were similar. During the 10-month fo
llow-up period, PUD-related inpatient and pharmacy adjusted costs were
similar, but adjusted outpatient costs in the H. pylori treated group
were lower than in the untreated group (difference, $508.00/person).
Total adjusted follow-up period costs mere $555.00/person less in the
H. pylori treated group (p = 0.05), Total 12-month costs in the H., py
lori treated group were $285.00/per person less than in untreated pati
ents, (p > 0.2); 30% of H. pylori treated patients were still receivin
g antisecretory therapy 1 yr after diagnosis, compared to 41.9% of unt
reated patients. Conclusions: H. pylori treatment is associated with a
decreased cost of follow-up care for patients with PUD, primarily due
to decreased outpatient utilization. (C) 1998 by Am. Coll. of Gastroe
nterology.